Logo
Login
$FENC
$10.62 +$0.47 (4.63%) Close

Company Executives

$FENC Management Team

Mr. Khalid Islam

Independent Chairman of the Board

Age 69
Compensation $182.1K USD
Sex Male

Mr. Jeffrey Hackman

Chief Executive Officer

Director

Age 63
Compensation $1.612M USD
Sex Male

Mr. Robert Andrade

Chief Financial Officer

Age 50
Compensation $1.761M USD
Sex Male

Dr. Pierre Sayad

Chief Medical Officer

Age 50
Compensation $483.5K USD
Sex Male

Board of Directors

From the proxy statement filed Apr 28, 2026
Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
Average tenure
11.2 years
from year joined
CEO also chairs the board
No
Dr. Khalid Islam
Director Age On board Independent Committees Other public boards 2025 pay Source
Jeff Hackman
CEO
 64 2024
2 years
 Not stated None stated None stated Paid as CEO
Chris A. Rallis
72 2011
15 years
 Independent None stated None stated Not stated
Dr. Marco Brughera
70 2016
10 years
 Independent None stated None stated $168,715
Dr. Khalid Islam
Board chair
 70 2014
12 years
 Independent None stated Gain Therapeutics Inc. (GANX) $214,019
Rostislav Raykov Leaving at the meeting
50 2009
17 years
 Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans